
Dr. Vanderslice has spent over 20 years leading teams focused on the development of small molecule compounds that bind and modulate the function of integrins and chemokine receptors. The majority of his professional career has been in the pharmaceutical industry, where he gained familiarity with each stage of the pipeline from discovery to progression into clinical trials. Dr. Vanderslice has led teams working on several pre-clinical programs involving efforts in drug screening, lead compound characterization, and the development of preclinical animal models.
See PublicationsTexas Heart Institute Positions
- Senior Investigator and Director, MCRL, Molecular Cardiology Research
Interests
- Non-invasive diagnostic imaging technologies
Education
-
Undergraduate:
University of Maryland
-
Postgraduate:
University of Texas at Austin (PhD)
-
Fellowships:
University of California San Francisco
Honors, Awards and Memberships
- Parker B. Francis Fellowship in Pulmonary Research, University of California, San Francisco, CA
- The Texas Heart Institute Academic Professional Staff
Publications
Recent News

Scientists have found a beautiful way to amplify vaccines
A technology platform co-invented by scientists at The Texas Heart Institute in partnership with 7 Hills Pharma CEO and co-founder...

The Texas Heart Institute Energizes BioHouston’s Chili Cook-Off
Continuing a favorite tradition, The Texas Heart Institute team brought their signature style to the 18th Annual BioHouston Chili Cook-Off...

The Texas Heart Institute’s Most Popular Scientific Articles from 2022
Altmetrics Attention Scores reveal the most popular articles from The Texas Heart Institute in 2022 The impact of a scientific...